{"id":1055460,"date":"2022-01-27T23:57:27","date_gmt":"2022-01-28T04:57:27","guid":{"rendered":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/uncategorized\/cystic-fibrosis-therapy-area-report-personas-of-online-stakeholders-key-unmet-needs-and-opportunities-for-pharma-to-engage-in-2021-prnewswire\/"},"modified":"2022-01-27T23:57:27","modified_gmt":"2022-01-28T04:57:27","slug":"cystic-fibrosis-therapy-area-report-personas-of-online-stakeholders-key-unmet-needs-and-opportunities-for-pharma-to-engage-in-2021-prnewswire","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/cf\/cystic-fibrosis-therapy-area-report-personas-of-online-stakeholders-key-unmet-needs-and-opportunities-for-pharma-to-engage-in-2021-prnewswire\/","title":{"rendered":"Cystic Fibrosis Therapy Area Report: Personas of Online Stakeholders, Key Unmet Needs and Opportunities for Pharma to Engage in 2021 &#8211; PRNewswire"},"content":{"rendered":"<p><p>DUBLIN, Jan. 27, 2022 \/PRNewswire\/ -- The \"Cystic Fibrosis (CF) Therapy Area Report\" report has been added to ResearchAndMarkets.com's offering.<\/p>\n<p>This Cystic Fibrosis (CF) therapy area report offers a comprehensive overview of the CF social media landscape, and provides insight into multiple stakeholder and company perspectives. Understand emergent signals and key trends amongst patients, caregivers, HCPs and digital opinion leaders, as well as the opportunities that exists for pharma to better engage with these groups.<\/p>\n<p>The report, which is based on both machine and human-led analysis, uncovers the personas of online stakeholders, the key unmet needs, and opportunities for pharma to engage with the online customers. Insights from our report can help boost pharma companies' engagement strategies, identify potential opportunities and mitigate business risks.<\/p>\n<p>Key Topics Covered:<\/p>\n<p>CF Social Media Landscape Overview<\/p>\n<p>The Patient Voice<\/p>\n<p>Clinical Conversations<\/p>\n<p>Competitive Intelligence<\/p>\n<p>Companies Mentioned <\/p>\n<p>For more information about this report visit <a href=\"https:\/\/www.researchandmarkets.com\/r\/2ftuiy\" rel=\"nofollow\">https:\/\/www.researchandmarkets.com\/r\/2ftuiy<\/a><\/p>\n<p>Media Contact: <\/p>\n<p>Research and Markets Laura Wood, Senior Manager [emailprotected] <\/p>\n<p>For E.S.T Office Hours Call +1-917-300-0470 For U.S.\/CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 <\/p>\n<p>U.S. Fax: 646-607-1904 Fax (outside U.S.): +353-1-481-1716<\/p>\n<p>SOURCE Research and Markets<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Original post:<\/p>\n<p><a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.prnewswire.com\/news-releases\/cystic-fibrosis-therapy-area-report-personas-of-online-stakeholders-key-unmet-needs-and-opportunities-for-pharma-to-engage-in-2021-301469724.html\" title=\"Cystic Fibrosis Therapy Area Report: Personas of Online Stakeholders, Key Unmet Needs and Opportunities for Pharma to Engage in 2021 - PRNewswire\">Cystic Fibrosis Therapy Area Report: Personas of Online Stakeholders, Key Unmet Needs and Opportunities for Pharma to Engage in 2021 - PRNewswire<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> DUBLIN, Jan. 27, 2022 \/PRNewswire\/ -- The \"Cystic Fibrosis (CF) Therapy Area Report\" report has been added to ResearchAndMarkets.com's offering <a href=\"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/cf\/cystic-fibrosis-therapy-area-report-personas-of-online-stakeholders-key-unmet-needs-and-opportunities-for-pharma-to-engage-in-2021-prnewswire\/\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":9,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[187753],"tags":[],"class_list":["post-1055460","post","type-post","status-publish","format-standard","hentry","category-cf"],"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1055460"}],"collection":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/users\/9"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/comments?post=1055460"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/posts\/1055460\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/media?parent=1055460"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/categories?post=1055460"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/prometheism-transhumanism-posthumanism\/wp-json\/wp\/v2\/tags?post=1055460"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}